Strategy and Risk Management
Go-to-Market Strategy
Target Market Focus: Initially, concentrate all resources and marketing capabilities on the 'exosome' sector to establish a strong foothold.
Build Trust and Secure Early Success Cases: Leverage the credibility of the Scientific Advisory Board (SAB) to build trust and create successful precedents with the first investment deals.
Expansion through Strategic Partnerships: Forge partnerships with global pharmaceutical companies, venture capitalists, and university research laboratories to expand the ecosystem.
Global Market Expansion: Starting with North America and Europe, gradually expand into the Asian market and other key regions.
Community Building and Growth Strategy
We will build a strong and active community through a multi-faceted approach that includes content leadership, contribution-based incentives (Contribute-to-Earn), an ambassador program, and regular community calls to foster engagement and loyalty.
Risk Management
Technical Risk
Multiple security audits, bug bounty programs, smart contract insurance, and a phased rollout.
Market Risk
Value linkage based on Real-World Assets (RWA), long-term holding incentives, and diversified treasury management.
Regulatory Risk
Proactive regulatory compliance, partnerships with global law firms, flexibility through the DAO structure, and gradual jurisdictional expansion.
Execution Risk
An experienced core team, a realistic roadmap, a strong Scientific Advisory Board, and performance-based compensation.
Investment-Specific Risk
Portfolio diversification, rigorous due diligence conducted by expert groups, and transparent disclosure of information.
Last updated